Trump rang the opening bell of the NYSE and Donald Trump rang the opening bell of the new york Stock Exchange on Thursday, which is a moment worth celebrating for the president-elect. He was named "Person of the Year" by Time magazine. The newspaper awarded this title to the incoming president, because he made a surprising political comeback in the November election and won re-election, and the Republican Party won control of the House and Senate.Spot gold hit $2,700 per ounce, down 0.65% in the day. COMEX gold futures fell more than 1.00% in the day and are now quoted at $2,729.00 per ounce.Caretaker Prime Minister of the Syrian Transitional Government: Primary and secondary schools and universities will resume classes next week. On December 12, local time, the reporter of the General Station was informed that the caretaker Prime Minister of the Syrian Transitional Government, Mohamed Al-Bashir, said that he would announce the appointment of the interim government in the next few days, and primary and secondary schools and universities would resume classes next week.
Spot gold hit $2,700 per ounce, down 0.65% in the day. COMEX gold futures fell more than 1.00% in the day and are now quoted at $2,729.00 per ounce.The annual PPI of the United States in November was 3%, and it was expected to be 2.6%. The previous value was revised from 2.40% to 2.6%. The monthly PPI rate of the United States in November was 0.4%, and it was expected to be 0.2%. The previous value was revised from 0.20% to 0.3%. The monthly rate of core PPI in the United States in November was 0.2%, which was expected to be 0.2%, and the previous value was revised from 0.00% to 0.30%. The annual core PPI of the United States in November was 3.4%, expected to be 3.2%, and the previous value was 3.10%.Market News: Trump Group plans to cooperate with DAR GLOBAL to build Trump Tower in Riyadh, Saudi Arabia.
Zhongyin Fashion: Zhongyin Group, the controlling shareholder, intends to transfer some shares of the company by agreement. Zhongyin Fashion announced that Zhongyin Group, the controlling shareholder of the company, intends to transfer 12,024,000 shares of the company's unrestricted shares to Wenwen Fund and Jinhe Investment by agreement transfer. The transferred shares each account for 5.01% of the company's total share capital, accounting for 5.07% of the company's total share capital after excluding the number of shares in the repurchase account. After this equity change, Zhongyin Group holds 94.284 million shares of the company, accounting for 39.29% of the company's total share capital, accounting for 39.79% of the company's total share capital after excluding the number of shares repurchased by the special account; Wenwen Fund and Jinhe Investment each hold 12.024 million shares of the company, each accounting for 5.01% of the company's total share capital, accounting for 5.07% of the company's total share capital after excluding the number of shares repurchased from the special account.Central Economic Work Conference: Keep the RMB exchange rate basically stable at a reasonable and balanced level. The Central Economic Work Conference was held in Beijing from December 11th to 12th. The meeting proposed to implement a moderately loose monetary policy. Give full play to the dual functions of the total amount and structure of monetary policy tools, reduce the RRR and interest rates in a timely manner, maintain sufficient liquidity, and match the scale of social financing and the growth of money supply with the expected goals of economic growth and overall price level. Keep the RMB exchange rate basically stable at a reasonable and balanced level. Explore and expand the macro-prudential and financial stability functions of the central bank, innovate financial instruments, and maintain the stability of the financial market.Baiyang Pharmaceutical Group signed an agreement with Peking University Hospital. On December 12, Baiyang Pharmaceutical Group signed a cooperation agreement with Peking University No.1 Hospital, and obtained the exclusive right to patent, clinical development and registration, production and marketing of "targeted integrin small molecule inhibitor" in Peking University Hospital.
Strategy guide 12-14
Strategy guide 12-14
Strategy guide